Director

Edward M. Basile

Director; Chairperson of the Nominating and Corporate Governance Committee·TransMedics Group, Inc.

About

Edward M. Basile, now retired, has served on the TransMedics Board since February 2016.

During his 25-year tenure with the law firm King & Spalding LLP he served as Chair of the firm's FDA and Life Sciences Practice and on its Policy and Compensation Committees, representing medical device, pharmaceutical and biotechnology companies before the U.S. Food and Drug Administration.

He earlier served in the FDA Chief Counsel's Office as Associate Chief Counsel for Drugs & Biologics and Associate Chief Counsel for Enforcement from 1975 to 1985, and holds a mechanical engineering degree from Lafayette College and a J.D. from George Washington University Law School.

Since February 2016
Age 78
Tenure 10 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director JT James R. Tobin Director; Chairperson of the Board TG Thomas J. Gunderson Director; Chairperson of the Compensation Committee EJ Edwin M. Kania, Jr. Director SL Stephanie Lovell Director MR Merilee Raines Director; Chairperson of the Audit Committee

Roles

Organization Role Dates Details
TransMedics Group, Inc. Director; Chairperson of the Nominating and Corporate Governance Committee February 2016–present Current role
King & Spalding LLP Chair of FDA and Life Sciences Practice; member of Policy and Compensation Committees 25-year tenure representing medical device, pharmaceutical and biotechnology companies before the FDA.
U.S. Food and Drug Administration (Chief Counsel's Office) Associate Chief Counsel for Drugs & Biologics; Associate Chief Counsel for Enforcement 1975-1985

Related

Company TransMedics Group, Inc. Company hub Person Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director Person James R. Tobin Director; Chairperson of the Board Person Thomas J. Gunderson Director; Chairperson of the Compensation Committee Person Edwin M. Kania, Jr. Director Person Stephanie Lovell Director Person Merilee Raines Director; Chairperson of the Audit Committee Person David Weill, M.D. Director Person Gerardo Hernandez Chief Financial Officer and Treasurer Person Giovanni Cecere Chief Commercial Officer Person Nicholas Corcoran Senior Vice President of Supply Chain and Operations Person Matthew Forsyth Senior Vice President, General Counsel and Corporate Secretary Person Tamer Khayal, M.D. Senior Vice President of International (former Chief Commercial Officer)
Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo